Related Experiment Video
Updated: Aug 13, 2025

09:01
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.1K
Chronic Myeloid Leukemia: Chronic Phase Presenting as Extramedullary Presentation
Vedant A Nanote1, Ojas A Mahajan2, Shilpa A Gaidhane2
1Department of Primary Care & General Practice, Kazan State Medical University, Kazan, RUS.
Cureus
|January 23, 2023
Summary
Chronic myeloid leukemia (CML) can manifest as myeloid sarcoma (MS), a rare extramedullary tumor. This case highlights MS in the parotid gland of a CML patient receiving imatinib therapy.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm often linked to the Philadelphia chromosome.
- Extramedullary disease, including myeloid sarcoma (MS), occurs in a subset of CML patients.
- Myeloid sarcoma, also known as chloroma, is a tumor of immature myeloid cells.
Observation:
- A case report of an elderly female patient diagnosed with CML in chronic phase is presented.
- The patient presented with myeloid sarcoma in the right parotid gland.
- The patient was undergoing imatinib therapy for CML.
Findings:
- This report details a rare presentation of myeloid sarcoma in the parotid gland in a patient with chronic myeloid leukemia.
- The case underscores the diverse clinical manifestations of CML beyond the typical bone marrow involvement.
- The green hue of myeloid sarcoma, due to myeloperoxidase, aids in its identification.
Implications:
- Recognizing myeloid sarcoma as an extramedullary manifestation of CML is crucial for accurate diagnosis and treatment.
- This case emphasizes the importance of considering unusual presentations in CML patients, even during therapy.
- Further research into the mechanisms and management of extramedullary CML is warranted.
Related Concept Videos
Disorders of Leukocytes
1.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.0K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K

